An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma

Ooi, Aikseng, Wong, Jing-Chii, Petillo, David, Roossien, Douglas, Perrier-Trudova, Victoria, Whitten, Douglas, Min, Bernice Wong Hui, Tan, Min-Han +9 more·2011·Cancer Cell
DOI 10.1016/j.ccr.2011.08.024

Cited by (405)

Items 401–405 of 405

  1. Next-Generation Immunohistochemical and RNA in Situ Hybridization Assays for Renal Neoplasia: Which Biomarkers Are Ready for Prime Time?
    Jacob E. Valk, Maria Tretiakova · 2026 · Cancers
  2. Itaconation and Succination as Metabolite-Derived Cysteine Modifications in Inflammatory Signalling: Biochemical Mechanisms, Chemoproteomic Mapping, and Therapeutic Opportunities
    Asif Ahmad Bhat, Shivkanya Fuloria, Riya Thapa, Nina Varghese, Rohini Karunakaran, Sumita Bhatia, Kamal Narain, Anupam Biswas, Sangita Biswas, Neeraj Kumar Fuloria · 2026 · Cell Biochemistry and Biophysics
  3. Uterine leiomyomas in HLRCC: a scoping review of presentation, histopathology, treatment patterns, and reproductive implications
    Reda Hessi, Ethan Bendayan, Lorena Alexandra Mija, Lydia Ouchene, Megha Udupa, Raquel Lazarowitz, Lili Fu, Shuk On Leung, Tania Cruz Marino, William David Foulkes et al. · 2026 · European Journal of Human Genetics
  4. BindingDB Entry 50019040: Optimization of 3-aminotetrahydrothiophene 1,1-dioxides with improved potency and efficacy as non-electrophilic antioxidant response element (ARE) activators.
    BindingDB · 2024 · UC San Diego
  5. BindingDB Entry 50022224: NRF2 inhibitors: Recent progress, future design and therapeutic potential.
    BindingDB · 2025 · UC San Diego